Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD [Phase 4]
Phase 4 trial evaluating the effects of ticagrelor and clopidogrel on platelet aggregation in patients with clopidogrel resistance and coron…
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG [Phase 3]
A Phase 3 trial comparing ticagrelor with aspirin for prevention of vascular events in patients undergoing CABG was terminated.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Parasternal Nerve Block in Cardiac Patients [Phase 2]
Phase 2 trial evaluating parasternal nerve block for postoperative pain in cardiac patients with coronary artery disease; the study complete…
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: BFPET for Regional Myocardial Perfusion Imaging [Phase 2]
Phase 2 clinical trial update for BFPET in regional myocardial perfusion imaging for coronary artery disease.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) [Phase 3]
Phase 3 REDUAL-PCI trial evaluating dabigatran-based dual therapy versus warfarin-based triple therapy in patients with atrial fibrillation …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-07-30FDA Approved: NITROGLYCERIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Nitroglycerin submitted by Prasco Laboratories, signaling an approval-related action affecting t…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets [Phase 3]
This is a Phase 3 clinical trial update on surgical revascularization outcomes comparing postoperative oral anticoagulation versus antiplate…
-
FDA approval · 2018-07-27FDA Approved: BIVALIRUDIN — Original Application (Eugia US LLC)
FDA approved the original application for BIVALIRUDIN by Eugia US LLC, granting a generic version of the anticoagulant for approved indicati…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes [Phase 4]
This entry reports a Phase 4 trial evaluating the combination of sitagliptin with insulin on the progression of coronary atherosclerosis in …
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
The update summarizes early participants' perspectives on informed consent for whole-genome sequencing in an NHGRI-supported study and the i…
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular Disease [NA]
This clinical trial update describes a study investigating novel strategies to improve cardiometabolic health and adherence to exercise in i…
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Absorb IV Randomized Controlled Trial [NA]
Clinical trial update for Absorb IV randomized trial; study status completed with results posted in 2018.
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: BIOFLOW-III VIP Russia Registry Orsiro Stent System
Update on the BIOFLOW-III VIP Russia registry evaluating the Orsiro Stent System for coronary artery disease; the current trial status is un…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations [Phase 4]
Phase 4 clinical trial update comparing BiOSS LIM C bifurcation stent with a second-generation drug-eluting stent in non-left-main coronary …
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: The Asahi Intecc PTCA Chronic Total Occlusion Study [NA]
The Asahi Intecc PTCA Chronic Total Occlusion study (NCT02379923) has completed and posted results as of July 18, 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Percutaneous Coronary Intervention With the Angiolite Drug-eluting Stent: an Optical Cohenrece Tomography Study [NA]
This clinical trial update reports the completion of a study evaluating the Angiolite drug-eluting stent for coronary artery disease using o…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial [NA]
Clinical trial comparing safety and efficacy of a drug-coated balloon with spot stenting of a drug-eluting stent versus a second-generation …
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: Metal Allergy In-Stent Restenosis Study [NA]
Clinical trial update on metal allergy and contact allergy in relation to in-stent restenosis in coronary artery disease; the current trial …
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: Current Treatment Strategy of Patients With Multivessel Disease or Left Main Coronary Artery Disease Indicated for Coronary Artery Bypass Graft Surgery
This clinical trial update discusses current treatment strategies for patients with multivessel disease or left main coronary artery disease…
-
FDA approval · 2018-07-16FDA Approved: BIVALIRUDIN — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' original application for generic bivalirudin.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Text Message Intervention to Improve Cardiac Rehab Participation [NA]
This entry reports a terminated clinical trial evaluating a text message intervention to boost participation in cardiac rehabilitation.
-
CLINICAL_TRIALS research · 2018-07-06Clinical Trial Update: TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery [NA]
This entry reports an ongoing clinical trial evaluating temporary spinal cord stimulation to prevent atrial fibrillation after cardiac surge…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease [NA]
This completed trial update discusses the optimal strategy for switching from clopidogrel to ticagrelor in patients with complex coronary ar…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Stem Cell Injection to Treat Heart Damage During Open Heart Surgery [Phase 1]
A Phase 1 clinical trial evaluating stem cell injections to treat heart damage during open-heart surgery has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: The Computed Tomography-derived Fractional Flow Reserve STAT Trial [NA]
The CT-derived fractional flow reserve STAT trial was terminated, with results posted in July 2018.